Q1 2008 revenues: +22.1% at constant USD rates
Sustained buoyant growth
| In EUR millions
|| Change at current USD rates
|| Change at constant USD rates
| Q1 (Jan - March)
|| + 13.1%
|| + 22.1%
Naturex posted revenues of EUR 24.0 million for the first three months of 2008, representing growth of 22.1% at constant USD rates and 13.1% at current USD rates.
Following the integration of HP Botanicals, Chart Corporation and the innovative active ingredients division of Berkem over 3 months in 2007 and in 2008, organic growth stood at 7.3% at constant USD rates.
Naturex has confirmed its 2008 targets of double-digit organic growth in constant dollars and of improved profitability with an operating margin of 11%. The integration of its two latest acquisitions is going extremely well.
Naturex will publish its revenue figures for the first half of 2008 in mid-July.
NATUREX has been listed since October 1996
Eurolist by Euronext Paris, segment B - ISIN: FR0000054694
Reuters NATU.LN - Bloomberg NTRX:FP